Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma 1 Year Total Returns (Daily): 23.06% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 23.06% |
May 16, 2024 | 29.26% |
May 15, 2024 | 19.43% |
May 14, 2024 | 18.13% |
May 13, 2024 | 16.22% |
May 10, 2024 | 10.59% |
May 09, 2024 | 21.61% |
May 08, 2024 | 22.26% |
May 07, 2024 | 28.14% |
May 06, 2024 | 36.73% |
May 03, 2024 | 31.97% |
May 02, 2024 | 10.69% |
May 01, 2024 | 8.67% |
April 30, 2024 | 4.08% |
April 29, 2024 | 0.61% |
April 26, 2024 | 20.35% |
April 25, 2024 | 19.74% |
April 24, 2024 | 15.95% |
April 23, 2024 | 18.24% |
April 22, 2024 | 17.21% |
April 19, 2024 | 6.80% |
April 18, 2024 | 15.40% |
April 17, 2024 | 19.80% |
April 16, 2024 | 19.28% |
April 15, 2024 | 18.69% |
Date | Value |
---|---|
April 12, 2024 | 27.29% |
April 11, 2024 | 32.08% |
April 10, 2024 | 58.93% |
April 09, 2024 | 51.56% |
April 08, 2024 | 52.15% |
April 05, 2024 | 57.08% |
April 04, 2024 | 45.27% |
April 03, 2024 | 70.75% |
April 02, 2024 | 89.44% |
April 01, 2024 | 96.89% |
March 28, 2024 | 92.98% |
March 27, 2024 | 113.5% |
March 26, 2024 | 122.1% |
March 25, 2024 | 119.7% |
March 22, 2024 | 146.0% |
March 21, 2024 | 105.2% |
March 20, 2024 | 89.25% |
March 19, 2024 | 57.68% |
March 18, 2024 | 109.7% |
March 15, 2024 | 87.90% |
March 14, 2024 | 61.54% |
March 13, 2024 | 46.60% |
March 12, 2024 | 79.07% |
March 11, 2024 | 46.98% |
March 08, 2024 | 64.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-69.06%
Minimum
Jun 13 2022
146.0%
Maximum
Mar 22 2024
-28.24%
Average
-30.33%
Median
Feb 06 2024
1 Year Total Returns (Daily) Benchmarks
Eyenovia Inc | -78.99% |
Cassava Sciences Inc | -8.58% |
Alpine Immune Sciences Inc | 657.2% |
Clearside Biomedical Inc | 25.96% |
Poseida Therapeutics Inc | 18.15% |